Graham Capital Management L.P. acquired a new position in shares of Cinemark Holdings, Inc. (NYSE:CNK - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 63,416 shares of the company's stock, valued at approximately $1,965,000. Graham Capital Management L.P. owned about 0.05% of Cinemark as of its most recent filing with the SEC.
Other hedge funds also recently made changes to their positions in the company. Russell Investments Group Ltd. lifted its stake in shares of Cinemark by 402.4% in the 4th quarter. Russell Investments Group Ltd. now owns 1,030 shares of the company's stock worth $32,000 after acquiring an additional 825 shares during the period. Aster Capital Management DIFC Ltd lifted its stake in shares of Cinemark by 380.0% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,896 shares of the company's stock worth $59,000 after acquiring an additional 1,501 shares during the period. R Squared Ltd acquired a new stake in shares of Cinemark in the 4th quarter worth $63,000. Quarry LP lifted its stake in shares of Cinemark by 41.8% in the 4th quarter. Quarry LP now owns 2,114 shares of the company's stock worth $65,000 after acquiring an additional 623 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of Cinemark by 44.9% in the 4th quarter. GAMMA Investing LLC now owns 2,926 shares of the company's stock worth $91,000 after acquiring an additional 906 shares during the period.
Insider Activity at Cinemark
In related news, insider Wanda Marie Gierhart sold 9,119 shares of the company's stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $27.00, for a total transaction of $246,213.00. Following the completion of the transaction, the insider now owns 147,414 shares of the company's stock, valued at approximately $3,980,178. This represents a 5.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.10% of the company's stock.
Cinemark Stock Performance
Shares of CNK opened at $31.25 on Monday. The company has a current ratio of 1.01, a quick ratio of 0.96 and a debt-to-equity ratio of 3.28. The stock has a market cap of $3.59 billion, a P/E ratio of 15.39 and a beta of 1.91. The company has a 50-day moving average of $26.96 and a two-hundred day moving average of $29.41. Cinemark Holdings, Inc. has a 12-month low of $16.32 and a 12-month high of $36.28.
Cinemark (NYSE:CNK - Get Free Report) last announced its quarterly earnings data on Friday, May 2nd. The company reported ($0.32) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.32). The business had revenue of $540.70 million for the quarter, compared to the consensus estimate of $604.62 million. Cinemark had a net margin of 10.16% and a return on equity of 65.83%. The company's quarterly revenue was down 6.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.19 earnings per share. As a group, research analysts predict that Cinemark Holdings, Inc. will post 1.93 EPS for the current fiscal year.
Cinemark Announces Dividend
The company also recently disclosed a -- dividend, which was paid on Wednesday, March 19th. Investors of record on Wednesday, March 5th were paid a dividend of $0.08 per share. The ex-dividend date of this dividend was Wednesday, March 5th. Cinemark's payout ratio is 21.05%.
Analysts Set New Price Targets
Several research firms have recently commented on CNK. Barrington Research restated an "outperform" rating and issued a $36.00 target price on shares of Cinemark in a research note on Monday, May 5th. Morgan Stanley reduced their price objective on shares of Cinemark from $40.00 to $35.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th. Macquarie reiterated an "outperform" rating and issued a $35.00 price objective on shares of Cinemark in a research note on Thursday, February 20th. JPMorgan Chase & Co. raised their price objective on shares of Cinemark from $34.00 to $35.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. Finally, Wedbush reiterated a "neutral" rating and issued a $32.00 price objective on shares of Cinemark in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $32.80.
Check Out Our Latest Research Report on Cinemark
Cinemark Company Profile
(
Free Report)
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cinemark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.
While Cinemark currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.